NOS3 and cardiovascular disorder: Notably, Cavin-2, in addition to its structural role, has been implicated in atherosclerosis progression in diabetic patients because of its modulation of eNOS activity and low-density lipoprotein (LDL) transcytosis, positioning it as a potential therapeutic target for cardiovascular disease [110].